ABSTRACT
Autocrine and paracrine insulin signaling may participate in the fine control of insulin secretion. In the present study, tissue distribution and protein amounts of the insulin receptor and its major substrates, insulin receptor substrate (IRS)-1 and IRS-2, were evaluated in a model of impaired glucose-induced insulin secretion, the protein-deficient rat. Immunoblot and RT-PCR studies showed that the insulin receptor and IRS-2 expression are increased, whilst IRS-1 protein and mRNA contents are decreased in pancreatic islets of protein-deficient rats. Immunohistochemical studies revealed that the insulin receptor and IRS-1 and -2 are present in the great majority of islet cells; however, the greatest staining was localized at the periphery, suggesting a co-localization with non-insulin-secreting cells. Exogenous insulin stimulation of isolated islets promoted higher insulin receptor and IRS-1 and -2 tyrosine phosphorylation in islets from protein-deficient rats, as compared with controls. Moreover, insulin-induced IRS-1- and IRS-2-associated phosphatidylinositol 3-kinase activity are increased in islets of protein-deficient rats. The reduction of IRS-1 and IRS-2 protein expression in islets isolated from protein-deficient rats by the use of antisense IRS-1 or IRS-2 phosphorthioate-modified oligonucleotides partially restored glucose-induced insulin secretion. Thus, the impairment of insulin cell signaling through members of the IRS family of proteins in isolated rat pancreatic islets improves glucose-induced insulin secretion. The present data reinforced the role of insulin paracrine and autocrine signaling in the control of its own secretion.
Subject(s)
Insulin/metabolism , Islets of Langerhans/metabolism , Phosphoproteins/metabolism , Protein Deficiency/metabolism , Animals , Glucagon/metabolism , Glucose/administration & dosage , Immunohistochemistry/methods , Insulin Receptor Substrate Proteins , Insulin Secretion , Intracellular Signaling Peptides and Proteins , Islets of Langerhans/chemistry , Male , Paracrine Communication/physiology , Phosphoproteins/analysis , Protein Deficiency/physiopathology , Rats , Rats, Wistar , Somatostatin/analysisABSTRACT
Pancreatic islet isolated from hyperinsulinemic obese rodents showed high glucose sensitivity to stimulation of insulin secretion. Current research evaluates the effect of subdiaphragmatic vagotomy on insulin secretion stimulated by glucose and by a cholinergic agonist carbachol (Cch) in islets isolated from monosodium L-glutamate (MSG)-obese rats. During the first 5 days after birth, MSG was intradermically injected into the cervical area of male Wistar rats (n=26). Control animals were injected with hyperosmotic saline solution (n=26). Vagotomy was performed on 30-day-old rats. On the 90th day, after a 12-h fast, the animals were killed. Pancreatic islets were isolated by collagenase. Batches of islets (n=30) were incubated for 60 min in glucose 2.8-20.0 mM or 0.1-2.0 mM Cch in the presence of glucose 8.3 mM. Released insulin was measured by radioimmunoassay. Insulin secretion stimulated by glucose in islets from MSG-obese rats shifted to the left when compared to that of controls, 63.8+/-3.9 and 42.2+/-2.6 ng/ml/islet/60 min (p<0.001), respectively. Vagotomy decreased by 56% (p<0.001) the secretion induced by all glucose concentrations in islets from MSG-obese rats. In the controls the operation caused a 30% (p<0.01) reduction. Cch stimulated insulin secretion in normal and obese rat islets. Response to obese rat islets was 1/3 less than normal ones (p<0.05). Vagotomy produced a greater potentiation of Cch induced insulin secretion on islets from obese rats. Data suggested that parasympathetic modulation is important to insulin secretion control.